Key facts
- This page summarizes Eric Dobmeier's Form 4 filing for CHINOOK THERAPEUTICS, INC..
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 11 Oct 2022, 16:33.
Eric Dobmeier - 06 Oct 2022 Form 4 Insider Report for CHINOOK THERAPEUTICS, INC.
- Reporting relationship
- President, CEO, Director
- Issuer ticker
- N/A
- Reported as of
- 06 Oct 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 11 Oct 2022, 16:33:10 UTC
- Prior SEC filing
- 27 Jun 2022
- Next SEC filing
- 02 Dec 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kirk Schumacher, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Eric Dobmeier filed Form 4 for CHINOOK THERAPEUTICS, INC. on 11 Oct 2022.
Change
- Previous filing in this sequence was filed on 27 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KDNY
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +30,796
- Change %
- +15%
- Price
- Shares after
- 236,676
- Date
- 06 Oct 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
KDNY
transaction
Derivative
Restricted Stock Units (RSU)
Options Exercise
- Transaction value
- $0
- Shares
- -30,796
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 30,797
- Date
- 06 Oct 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 30,796
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Restricted stock units convert into common stock on a one-for-one basis.
Footnote F2
Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
Footnote F3
The RSUs vests as to one-third (1/3) of the total restricted stock units in equal annual installments beginning on October 6, 2021, until fully vested subject to the reporting person's provision of service to the Issuer on each vesting date.